

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.75215029 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.75215029 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.54049090 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.54049090 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.07568161 |
| 6 | lysine metabolic process (GO:0006553) | 5.67915170 |
| 7 | lysine catabolic process (GO:0006554) | 5.67915170 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.55472300 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.55472300 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.55472300 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.49571082 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.40673616 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.31710450 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.29703923 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.24473593 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.23361112 |
| 17 | cysteine metabolic process (GO:0006534) | 5.17037848 |
| 18 | bile acid biosynthetic process (GO:0006699) | 5.15188290 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.05146472 |
| 20 | amino-acid betaine metabolic process (GO:0006577) | 4.84265384 |
| 21 | homocysteine metabolic process (GO:0050667) | 4.74887543 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.72871815 |
| 23 | urea cycle (GO:0000050) | 4.67848162 |
| 24 | urea metabolic process (GO:0019627) | 4.67848162 |
| 25 | regulation of triglyceride catabolic process (GO:0010896) | 4.65790395 |
| 26 | * fatty acid beta-oxidation (GO:0006635) | 4.61923865 |
| 27 | cellular ketone body metabolic process (GO:0046950) | 4.58952899 |
| 28 | valine metabolic process (GO:0006573) | 4.54572571 |
| 29 | alpha-amino acid catabolic process (GO:1901606) | 4.49738660 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.49332739 |
| 31 | * short-chain fatty acid metabolic process (GO:0046459) | 4.46595421 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 4.45517695 |
| 33 | branched-chain amino acid catabolic process (GO:0009083) | 4.42387939 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.41048704 |
| 35 | * fatty acid oxidation (GO:0019395) | 4.37189353 |
| 36 | bile acid metabolic process (GO:0008206) | 4.37079087 |
| 37 | 2-oxoglutarate metabolic process (GO:0006103) | 4.35830779 |
| 38 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.35792678 |
| 39 | nitrogen cycle metabolic process (GO:0071941) | 4.35385713 |
| 40 | acetyl-CoA metabolic process (GO:0006084) | 4.33067559 |
| 41 | protein carboxylation (GO:0018214) | 4.31097552 |
| 42 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.31097552 |
| 43 | * lipid oxidation (GO:0034440) | 4.30113546 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 4.29808965 |
| 45 | cellular amino acid catabolic process (GO:0009063) | 4.29386150 |
| 46 | regulation of protein activation cascade (GO:2000257) | 4.29346734 |
| 47 | exogenous drug catabolic process (GO:0042738) | 4.27257292 |
| 48 | * fatty acid catabolic process (GO:0009062) | 4.24628857 |
| 49 | behavioral response to nicotine (GO:0035095) | 4.22157789 |
| 50 | branched-chain amino acid metabolic process (GO:0009081) | 4.18372376 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 4.17569280 |
| 52 | negative regulation of fibrinolysis (GO:0051918) | 4.15975180 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.14107516 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.14107516 |
| 55 | ethanol oxidation (GO:0006069) | 4.10707139 |
| 56 | * monocarboxylic acid catabolic process (GO:0072329) | 4.09960942 |
| 57 | regulation of complement activation (GO:0030449) | 4.05542757 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.05320019 |
| 59 | tyrosine metabolic process (GO:0006570) | 4.03781880 |
| 60 | * organic acid catabolic process (GO:0016054) | 4.02402479 |
| 61 | * carboxylic acid catabolic process (GO:0046395) | 4.02402479 |
| 62 | carnitine metabolic process (GO:0009437) | 4.02401067 |
| 63 | regulation of fibrinolysis (GO:0051917) | 3.99879062 |
| 64 | reverse cholesterol transport (GO:0043691) | 3.97898565 |
| 65 | intraciliary transport (GO:0042073) | 3.97592370 |
| 66 | ketone body metabolic process (GO:1902224) | 3.94585369 |
| 67 | protein-lipid complex remodeling (GO:0034368) | 3.94302595 |
| 68 | macromolecular complex remodeling (GO:0034367) | 3.94302595 |
| 69 | plasma lipoprotein particle remodeling (GO:0034369) | 3.94302595 |
| 70 | fatty acid transmembrane transport (GO:1902001) | 3.92873740 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 3.90894013 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.90475356 |
| 73 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.87792073 |
| 74 | glutamate metabolic process (GO:0006536) | 3.86608485 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 3.84291045 |
| 76 | amine catabolic process (GO:0009310) | 3.83416406 |
| 77 | cellular biogenic amine catabolic process (GO:0042402) | 3.83416406 |
| 78 | regulation of cholesterol esterification (GO:0010872) | 3.80890105 |
| 79 | glycine metabolic process (GO:0006544) | 3.78063586 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.77094787 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 3.74411366 |
| 82 | drug transmembrane transport (GO:0006855) | 3.74356736 |
| 83 | drug catabolic process (GO:0042737) | 3.68366666 |
| 84 | positive regulation of lipid catabolic process (GO:0050996) | 3.67447823 |
| 85 | negative regulation of sterol transport (GO:0032372) | 3.66967154 |
| 86 | negative regulation of cholesterol transport (GO:0032375) | 3.66967154 |
| 87 | * biotin metabolic process (GO:0006768) | 3.66642088 |
| 88 | nucleobase catabolic process (GO:0046113) | 3.65974362 |
| 89 | phospholipid homeostasis (GO:0055091) | 3.65387786 |
| 90 | carnitine shuttle (GO:0006853) | 3.65001031 |
| 91 | regulation of sequestering of triglyceride (GO:0010889) | 3.64129148 |
| 92 | cellular glucuronidation (GO:0052695) | 3.61947608 |
| 93 | phospholipid efflux (GO:0033700) | 3.60134052 |
| 94 | urate metabolic process (GO:0046415) | 3.57733283 |
| 95 | positive regulation of fatty acid oxidation (GO:0046321) | 3.54588890 |
| 96 | oxidative demethylation (GO:0070989) | 3.52851886 |
| 97 | bile acid and bile salt transport (GO:0015721) | 3.49866933 |
| 98 | serine family amino acid biosynthetic process (GO:0009070) | 3.47370910 |
| 99 | regulation of cholesterol metabolic process (GO:0090181) | 3.45077657 |
| 100 | tricarboxylic acid metabolic process (GO:0072350) | 3.41869247 |
| 101 | epithelial cilium movement (GO:0003351) | 3.41338282 |
| 102 | * small molecule catabolic process (GO:0044282) | 3.36559315 |
| 103 | imidazole-containing compound metabolic process (GO:0052803) | 3.36503011 |
| 104 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.35891010 |
| 105 | succinate metabolic process (GO:0006105) | 3.34763914 |
| 106 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.33030627 |
| 107 | negative regulation of lipase activity (GO:0060192) | 3.32912894 |
| 108 | low-density lipoprotein particle remodeling (GO:0034374) | 3.31094004 |
| 109 | cilium movement (GO:0003341) | 3.29720056 |
| 110 | epoxygenase P450 pathway (GO:0019373) | 3.02333868 |
| 111 | L-fucose catabolic process (GO:0042355) | 2.96344686 |
| 112 | fucose catabolic process (GO:0019317) | 2.96344686 |
| 113 | L-fucose metabolic process (GO:0042354) | 2.96344686 |
| 114 | protein polyglutamylation (GO:0018095) | 2.96109601 |
| 115 | nonmotile primary cilium assembly (GO:0035058) | 2.90826728 |
| 116 | neural tube formation (GO:0001841) | 2.86556943 |
| 117 | gamma-aminobutyric acid transport (GO:0015812) | 2.85091129 |
| 118 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.83146057 |
| 119 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.82549183 |
| 120 | photoreceptor cell maintenance (GO:0045494) | 2.80549774 |
| 121 | omega-hydroxylase P450 pathway (GO:0097267) | 2.80237009 |
| 122 | uronic acid metabolic process (GO:0006063) | 2.71586752 |
| 123 | glucuronate metabolic process (GO:0019585) | 2.71586752 |
| 124 | axonemal dynein complex assembly (GO:0070286) | 2.67804451 |
| 125 | cilium morphogenesis (GO:0060271) | 2.67085562 |
| 126 | retinal ganglion cell axon guidance (GO:0031290) | 2.65359164 |
| 127 | cilium organization (GO:0044782) | 2.64307956 |
| 128 | cilium assembly (GO:0042384) | 2.63349484 |
| 129 | drug metabolic process (GO:0017144) | 2.63254989 |
| 130 | axoneme assembly (GO:0035082) | 2.61998342 |
| 131 | response to nitrosative stress (GO:0051409) | 2.58734572 |
| 132 | regulation of hexokinase activity (GO:1903299) | 2.57530461 |
| 133 | regulation of glucokinase activity (GO:0033131) | 2.57530461 |
| 134 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.56237911 |
| 135 | S-adenosylmethionine metabolic process (GO:0046500) | 2.56170070 |
| 136 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.53675511 |
| 137 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.53578068 |
| 138 | regulation of cilium movement (GO:0003352) | 2.51788254 |
| 139 | L-serine metabolic process (GO:0006563) | 2.50522292 |
| 140 | presynaptic membrane assembly (GO:0097105) | 2.49956423 |
| 141 | inner ear receptor stereocilium organization (GO:0060122) | 2.49516920 |
| 142 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.48061766 |
| 143 | regulation of action potential (GO:0098900) | 2.45434072 |
| 144 | protein neddylation (GO:0045116) | 2.43012563 |
| 145 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.42030954 |
| 146 | dorsal/ventral axis specification (GO:0009950) | 2.41707084 |
| 147 | C4-dicarboxylate transport (GO:0015740) | 2.39584937 |
| 148 | phenylpropanoid metabolic process (GO:0009698) | 2.38407610 |
| 149 | somite development (GO:0061053) | 2.37239929 |
| 150 | reflex (GO:0060004) | 2.37023987 |
| 151 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.36798618 |
| 152 | detection of light stimulus involved in visual perception (GO:0050908) | 2.36798618 |
| 153 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.36543564 |
| 154 | olfactory bulb development (GO:0021772) | 2.36103499 |
| 155 | cellular response to sterol (GO:0036315) | 2.36089106 |
| 156 | behavioral response to ethanol (GO:0048149) | 2.33911343 |
| 157 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.33183479 |
| 158 | short-term memory (GO:0007614) | 2.32335558 |
| 159 | arginine metabolic process (GO:0006525) | 2.30650032 |
| 160 | alkaloid metabolic process (GO:0009820) | 2.26999593 |
| 161 | nephron tubule morphogenesis (GO:0072078) | 2.25773939 |
| 162 | nephron epithelium morphogenesis (GO:0072088) | 2.25773939 |
| 163 | ubiquinone metabolic process (GO:0006743) | 2.25391054 |
| 164 | limb development (GO:0060173) | 2.25067507 |
| 165 | appendage development (GO:0048736) | 2.25067507 |
| 166 | presynaptic membrane organization (GO:0097090) | 2.24921413 |
| 167 | limb bud formation (GO:0060174) | 2.24793646 |
| 168 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.24500625 |
| 169 | amino acid salvage (GO:0043102) | 2.22846031 |
| 170 | L-methionine salvage (GO:0071267) | 2.22846031 |
| 171 | L-methionine biosynthetic process (GO:0071265) | 2.22846031 |
| 172 | smoothened signaling pathway (GO:0007224) | 2.22208498 |
| 173 | regulation of gene silencing by RNA (GO:0060966) | 2.21203226 |
| 174 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.21203226 |
| 175 | regulation of gene silencing by miRNA (GO:0060964) | 2.21203226 |
| 176 | dopamine transport (GO:0015872) | 2.20525082 |
| 177 | determination of left/right symmetry (GO:0007368) | 2.20156624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.67558160 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.26149889 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.70197160 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.03945106 |
| 5 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.84701270 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91091350 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.37184953 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83244488 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.58598965 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.51662950 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.47476977 |
| 12 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.44535936 |
| 13 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.06258285 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.68682277 |
| 15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.66500308 |
| 16 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.61327367 |
| 17 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.49929850 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.44821252 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.33564734 |
| 20 | VDR_22108803_ChIP-Seq_LS180_Human | 2.33409511 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.28704629 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.26217180 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.26193023 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.24159809 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 2.22121339 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 2.20824835 |
| 27 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.12736091 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.05637852 |
| 29 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04332877 |
| 30 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7871461 |
| 31 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.96138153 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94455327 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89762376 |
| 34 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.87784387 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85376130 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 1.82839685 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.82356818 |
| 38 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.82052320 |
| 39 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.77897963 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.71645344 |
| 41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71439684 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.64727992 |
| 43 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61975763 |
| 44 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.60245698 |
| 45 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.57925116 |
| 46 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.57376353 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.55285180 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.54921801 |
| 49 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.52995648 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.50776541 |
| 51 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.49595559 |
| 52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.47646376 |
| 53 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47646376 |
| 54 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47492823 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46987307 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46439602 |
| 57 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.45772722 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.45772722 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.43488307 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42003946 |
| 61 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41590815 |
| 62 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41224115 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40104220 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39942598 |
| 65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.39706990 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.37149383 |
| 67 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.35850851 |
| 68 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.33155833 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33099979 |
| 70 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.32643111 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31410663 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30795070 |
| 73 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.28984323 |
| 74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28536707 |
| 75 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.28508251 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24519397 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24498727 |
| 78 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.23992032 |
| 79 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23556688 |
| 80 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.23149449 |
| 81 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.22600308 |
| 82 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.22048898 |
| 83 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20995805 |
| 84 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20788056 |
| 85 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20148779 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19652232 |
| 87 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.19429931 |
| 88 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17050095 |
| 89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.16450910 |
| 90 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14357301 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13833918 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13833918 |
| 93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13760461 |
| 94 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13528031 |
| 95 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.12839221 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09649546 |
| 97 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08487457 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05991287 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05769313 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.04151051 |
| 101 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03556412 |
| 102 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02890374 |
| 103 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02838738 |
| 104 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02837458 |
| 105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02503633 |
| 106 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02381525 |
| 107 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00989916 |
| 108 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00953410 |
| 109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00733275 |
| 110 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.98993812 |
| 111 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97812361 |
| 112 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97402615 |
| 113 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97295701 |
| 114 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96598607 |
| 115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95022244 |
| 116 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94365125 |
| 117 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93473933 |
| 118 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.92957631 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92064862 |
| 120 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91952222 |
| 121 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91522416 |
| 122 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91494298 |
| 123 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91400133 |
| 124 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.91174541 |
| 125 | TBL1_22424771_ChIP-Seq_293T_Human | 0.91012649 |
| 126 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90913779 |
| 127 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86483802 |
| 128 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86455915 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85511819 |
| 130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85347844 |
| 131 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84977905 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82837468 |
| 133 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80888111 |
| 134 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80888111 |
| 135 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80759352 |
| 136 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78714848 |
| 137 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.77458074 |
| 138 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.76979574 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76930062 |
| 140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76930062 |
| 141 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76535962 |
| 142 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.75258682 |
| 143 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.73956735 |
| 144 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.71816540 |
| 145 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71050146 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69734059 |
| 147 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67955978 |
| 148 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66402147 |
| 149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63641541 |
| 150 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63557355 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.62537989 |
| 152 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.60191725 |
| 153 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.59626761 |
| 154 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.59322265 |
| 155 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.58858054 |
| 156 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.58313905 |
| 157 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.58028599 |
| 158 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57987728 |
| 159 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56678881 |
| 160 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.56503765 |
| 161 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.55680552 |
| 162 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55610552 |
| 163 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54816719 |
| 164 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.54707599 |
| 165 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.54446698 |
| 166 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54411600 |
| 167 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54050868 |
| 168 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53193019 |
| 169 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52541213 |
| 170 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.51579622 |
| 171 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51003373 |
| 172 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49650720 |
| 173 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49589743 |
| 174 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48458707 |
| 175 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.47391255 |
| 176 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.47357013 |
| 177 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47185713 |
| 178 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.47160623 |
| 179 | GATA2_19941826_ChIP-Seq_K562_Human | 0.46842249 |
| 180 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.46824665 |
| 181 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.46775103 |
| 182 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46592561 |
| 183 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45927313 |
| 184 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.44746423 |
| 185 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44431441 |
| 186 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.44232456 |
| 187 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.44040152 |
| 188 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.43696109 |
| 189 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.43066295 |
| 190 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.42893704 |
| 191 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.41766926 |
| 192 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41459140 |
| 193 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.41157374 |
| 194 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40821786 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.42986263 |
| 2 | MP0005360_urolithiasis | 7.02147159 |
| 3 | MP0005365_abnormal_bile_salt | 5.84134972 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.65586038 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.31430651 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.75135370 |
| 7 | MP0003252_abnormal_bile_duct | 3.42230406 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41332940 |
| 9 | MP0005332_abnormal_amino_acid | 3.16719555 |
| 10 | MP0003195_calcinosis | 2.90085851 |
| 11 | MP0005083_abnormal_biliary_tract | 2.82161297 |
| 12 | MP0001666_abnormal_nutrient_absorption | 2.64684746 |
| 13 | MP0006292_abnormal_olfactory_placode | 2.60896018 |
| 14 | MP0009840_abnormal_foam_cell | 2.51703945 |
| 15 | MP0005670_abnormal_white_adipose | 2.45878808 |
| 16 | MP0003880_abnormal_central_pattern | 2.45430133 |
| 17 | MP0003890_abnormal_embryonic-extraembry | 2.34028999 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.26444831 |
| 19 | MP0003136_yellow_coat_color | 2.24741644 |
| 20 | MP0001485_abnormal_pinna_reflex | 2.15172835 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.14378566 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 2.10682810 |
| 23 | * MP0000609_abnormal_liver_physiology | 2.05284193 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.99280452 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.96037532 |
| 26 | MP0000566_synostosis | 1.94550099 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.94180325 |
| 28 | MP0002102_abnormal_ear_morphology | 1.93019023 |
| 29 | MP0003122_maternal_imprinting | 1.91311489 |
| 30 | MP0006072_abnormal_retinal_apoptosis | 1.90591439 |
| 31 | MP0005551_abnormal_eye_electrophysiolog | 1.88895916 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.87188757 |
| 33 | MP0004130_abnormal_muscle_cell | 1.82442798 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.80866423 |
| 35 | MP0001984_abnormal_olfaction | 1.72582045 |
| 36 | * MP0009643_abnormal_urine_homeostasis | 1.70341792 |
| 37 | MP0001764_abnormal_homeostasis | 1.69739197 |
| 38 | MP0003787_abnormal_imprinting | 1.69629110 |
| 39 | MP0006036_abnormal_mitochondrial_physio | 1.69234984 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.65661756 |
| 41 | MP0001293_anophthalmia | 1.64190940 |
| 42 | MP0002938_white_spotting | 1.63566522 |
| 43 | MP0004133_heterotaxia | 1.62247037 |
| 44 | MP0003868_abnormal_feces_composition | 1.59432082 |
| 45 | MP0003186_abnormal_redox_activity | 1.58222077 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.55515810 |
| 47 | MP0005666_abnormal_adipose_tissue | 1.53350904 |
| 48 | MP0000778_abnormal_nervous_system | 1.53164526 |
| 49 | MP0002736_abnormal_nociception_after | 1.51799277 |
| 50 | MP0001529_abnormal_vocalization | 1.49333375 |
| 51 | MP0000631_abnormal_neuroendocrine_gland | 1.44283873 |
| 52 | MP0005253_abnormal_eye_physiology | 1.43707282 |
| 53 | MP0005377_hearing/vestibular/ear_phenot | 1.43292674 |
| 54 | MP0003878_abnormal_ear_physiology | 1.43292674 |
| 55 | MP0001486_abnormal_startle_reflex | 1.40991264 |
| 56 | MP0005499_abnormal_olfactory_system | 1.39871383 |
| 57 | MP0005394_taste/olfaction_phenotype | 1.39871383 |
| 58 | MP0001968_abnormal_touch/_nociception | 1.38580392 |
| 59 | MP0002971_abnormal_brown_adipose | 1.38246625 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.37223915 |
| 61 | MP0008789_abnormal_olfactory_epithelium | 1.36893141 |
| 62 | MP0003121_genomic_imprinting | 1.36877399 |
| 63 | MP0003937_abnormal_limbs/digits/tail_de | 1.36132658 |
| 64 | MP0010030_abnormal_orbit_morphology | 1.34153409 |
| 65 | MP0004043_abnormal_pH_regulation | 1.31257032 |
| 66 | MP0004142_abnormal_muscle_tone | 1.28952403 |
| 67 | MP0002233_abnormal_nose_morphology | 1.28843175 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.28074815 |
| 69 | MP0009046_muscle_twitch | 1.26329279 |
| 70 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24828478 |
| 71 | MP0002234_abnormal_pharynx_morphology | 1.24670535 |
| 72 | MP0002272_abnormal_nervous_system | 1.24257972 |
| 73 | MP0009697_abnormal_copulation | 1.21403477 |
| 74 | MP0003646_muscle_fatigue | 1.18924539 |
| 75 | MP0002876_abnormal_thyroid_physiology | 1.18702006 |
| 76 | MP0005535_abnormal_body_temperature | 1.18657120 |
| 77 | MP0004145_abnormal_muscle_electrophysio | 1.18126886 |
| 78 | MP0002557_abnormal_social/conspecific_i | 1.17891806 |
| 79 | MP0009745_abnormal_behavioral_response | 1.17610246 |
| 80 | MP0010386_abnormal_urinary_bladder | 1.16223907 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.15732518 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 1.15519401 |
| 83 | * MP0002078_abnormal_glucose_homeostasis | 1.14759326 |
| 84 | MP0001986_abnormal_taste_sensitivity | 1.14143078 |
| 85 | MP0000049_abnormal_middle_ear | 1.12110992 |
| 86 | MP0000598_abnormal_liver_morphology | 1.10665316 |
| 87 | MP0000372_irregular_coat_pigmentation | 1.08648262 |
| 88 | MP0005647_abnormal_sex_gland | 1.08181833 |
| 89 | MP0005451_abnormal_body_composition | 1.06094899 |
| 90 | MP0002735_abnormal_chemical_nociception | 1.05917808 |
| 91 | MP0005334_abnormal_fat_pad | 1.05620754 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 1.04923532 |
| 93 | MP0005195_abnormal_posterior_eye | 1.03013664 |
| 94 | MP0000383_abnormal_hair_follicle | 1.00979536 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 1.00450271 |
| 96 | MP0004742_abnormal_vestibular_system | 1.00283591 |
| 97 | MP0000427_abnormal_hair_cycle | 0.98373529 |
| 98 | MP0009764_decreased_sensitivity_to | 0.97648773 |
| 99 | MP0000026_abnormal_inner_ear | 0.96720227 |
| 100 | MP0003119_abnormal_digestive_system | 0.95896965 |
| 101 | MP0005084_abnormal_gallbladder_morpholo | 0.94383650 |
| 102 | MP0006035_abnormal_mitochondrial_morpho | 0.94153587 |
| 103 | MP0002752_abnormal_somatic_nervous | 0.93622914 |
| 104 | MP0009642_abnormal_blood_homeostasis | 0.92668030 |
| 105 | MP0005391_vision/eye_phenotype | 0.92177439 |
| 106 | MP0003137_abnormal_impulse_conducting | 0.92121180 |
| 107 | MP0002572_abnormal_emotion/affect_behav | 0.91623406 |
| 108 | * MP0001756_abnormal_urination | 0.91215273 |
| 109 | MP0005386_behavior/neurological_phenoty | 0.90774976 |
| 110 | MP0004924_abnormal_behavior | 0.90774976 |
| 111 | MP0009763_increased_sensitivity_to | 0.90561793 |
| 112 | MP0005187_abnormal_penis_morphology | 0.90277306 |
| 113 | MP0001324_abnormal_eye_pigmentation | 0.90105928 |
| 114 | MP0003705_abnormal_hypodermis_morpholog | 0.90083558 |
| 115 | MP0002067_abnormal_sensory_capabilities | 0.89555378 |
| 116 | MP0004185_abnormal_adipocyte_glucose | 0.88928086 |
| 117 | MP0003938_abnormal_ear_development | 0.88830885 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.87921107 |
| 119 | MP0001286_abnormal_eye_development | 0.87361113 |
| 120 | MP0002734_abnormal_mechanical_nocicepti | 0.87084341 |
| 121 | MP0008469_abnormal_protein_level | 0.85609236 |
| 122 | MP0005423_abnormal_somatic_nervous | 0.85023354 |
| 123 | MP0000604_amyloidosis | 0.84689058 |
| 124 | MP0002751_abnormal_autonomic_nervous | 0.84631307 |
| 125 | MP0004885_abnormal_endolymph | 0.84395448 |
| 126 | MP0000955_abnormal_spinal_cord | 0.83979107 |
| 127 | MP0001661_extended_life_span | 0.83954452 |
| 128 | MP0001963_abnormal_hearing_physiology | 0.82396379 |
| 129 | MP0005330_cardiomyopathy | 0.81420438 |
| 130 | MP0001299_abnormal_eye_distance/ | 0.80483316 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.79517062 |
| 132 | MP0005448_abnormal_energy_balance | 0.78915928 |
| 133 | MP0003011_delayed_dark_adaptation | 0.78658074 |
| 134 | MP0005376_homeostasis/metabolism_phenot | 0.78134514 |
| 135 | MP0005266_abnormal_metabolism | 0.78118347 |
| 136 | MP0003635_abnormal_synaptic_transmissio | 0.76741753 |
| 137 | MP0002136_abnormal_kidney_physiology | 0.73553291 |
| 138 | MP0005058_abnormal_lysosome_morphology | 0.72728807 |
| 139 | MP0009115_abnormal_fat_cell | 0.71011906 |
| 140 | MP0004147_increased_porphyrin_level | 0.70173512 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.66627947 |
| 142 | MP0002970_abnormal_white_adipose | 0.65247796 |
| 143 | MP0001765_abnormal_ion_homeostasis | 0.65034271 |
| 144 | MP0002269_muscular_atrophy | 0.64330522 |
| 145 | MP0003690_abnormal_glial_cell | 0.64312216 |
| 146 | MP0003953_abnormal_hormone_level | 0.64204495 |
| 147 | MP0004215_abnormal_myocardial_fiber | 0.62043470 |
| 148 | MP0005408_hypopigmentation | 0.61371532 |
| 149 | MP0003724_increased_susceptibility_to | 0.60812079 |
| 150 | MP0002928_abnormal_bile_duct | 0.59647836 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.56483305 |
| 152 | MP0002254_reproductive_system_inflammat | 0.56003881 |
| 153 | MP0003329_amyloid_beta_deposits | 0.54647166 |
| 154 | MP0004036_abnormal_muscle_relaxation | 0.52250863 |
| 155 | MP0001853_heart_inflammation | 0.50105698 |
| 156 | MP0003959_abnormal_lean_body | 0.48194972 |
| 157 | MP0006138_congestive_heart_failure | 0.47459277 |
| 158 | MP0000749_muscle_degeneration | 0.47014640 |
| 159 | MP0001544_abnormal_cardiovascular_syste | 0.46927761 |
| 160 | MP0005385_cardiovascular_system_phenoty | 0.46927761 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.46596292 |
| 162 | MP0004087_abnormal_muscle_fiber | 0.45527682 |
| 163 | MP0002822_catalepsy | 0.44504702 |
| 164 | MP0005452_abnormal_adipose_tissue | 0.43284690 |
| 165 | MP0009384_cardiac_valve_regurgitation | 0.40174640 |
| 166 | MP0000003_abnormal_adipose_tissue | 0.40097376 |
| 167 | MP0008775_abnormal_heart_ventricle | 0.39727941 |
| 168 | MP0008961_abnormal_basal_metabolism | 0.39265005 |
| 169 | MP0004782_abnormal_surfactant_physiolog | 0.39163960 |
| 170 | MP0008872_abnormal_physiological_respon | 0.39156752 |
| 171 | MP0002972_abnormal_cardiac_muscle | 0.38911841 |
| 172 | MP0002168_other_aberrant_phenotype | 0.38619365 |
| 173 | MP0001944_abnormal_pancreas_morphology | 0.38281223 |
| 174 | MP0002332_abnormal_exercise_endurance | 0.38129447 |
| 175 | MP0005620_abnormal_muscle_contractility | 0.37918644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.96059379 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 5.66500807 |
| 3 | Deep venous thrombosis (HP:0002625) | 5.31573048 |
| 4 | Xanthomatosis (HP:0000991) | 5.08769222 |
| 5 | * Hyperglycinuria (HP:0003108) | 5.06501260 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.95118298 |
| 7 | Ketosis (HP:0001946) | 4.95068691 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.85231338 |
| 9 | * Hyperammonemia (HP:0001987) | 4.83293237 |
| 10 | * Abnormality of glycine metabolism (HP:0010895) | 4.67873634 |
| 11 | * Abnormality of serine family amino acid metabolism (HP:0010894) | 4.67873634 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 4.60859609 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.50964734 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 4.43354675 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.42320287 |
| 16 | Ketoacidosis (HP:0001993) | 4.38942329 |
| 17 | * Hyperglycinemia (HP:0002154) | 4.35052420 |
| 18 | Complement deficiency (HP:0004431) | 4.30239838 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07849993 |
| 20 | Dicarboxylic aciduria (HP:0003215) | 3.91943844 |
| 21 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.91943844 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.88759321 |
| 23 | Pancreatic cysts (HP:0001737) | 3.81439183 |
| 24 | Hypolipoproteinemia (HP:0010981) | 3.78515324 |
| 25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.77883652 |
| 26 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.68484449 |
| 27 | Hypoalphalipoproteinemia (HP:0003233) | 3.65395845 |
| 28 | True hermaphroditism (HP:0010459) | 3.60226606 |
| 29 | Epidermoid cyst (HP:0200040) | 3.59900388 |
| 30 | Abnormality of methionine metabolism (HP:0010901) | 3.58016990 |
| 31 | Pancreatic fibrosis (HP:0100732) | 3.54469375 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.53071339 |
| 33 | Nephronophthisis (HP:0000090) | 3.51582203 |
| 34 | Molar tooth sign on MRI (HP:0002419) | 3.46325840 |
| 35 | Abnormality of midbrain morphology (HP:0002418) | 3.46325840 |
| 36 | Joint hemorrhage (HP:0005261) | 3.43414746 |
| 37 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.42182563 |
| 38 | Generalized aminoaciduria (HP:0002909) | 3.37147855 |
| 39 | Chronic hepatic failure (HP:0100626) | 3.37054458 |
| 40 | Fat malabsorption (HP:0002630) | 3.30341441 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 3.27075228 |
| 42 | * Abnormality of serum amino acid levels (HP:0003112) | 3.25876188 |
| 43 | Cerebral edema (HP:0002181) | 3.20890080 |
| 44 | Gout (HP:0001997) | 3.19785040 |
| 45 | * Metabolic acidosis (HP:0001942) | 3.18619834 |
| 46 | Abnormality of purine metabolism (HP:0004352) | 3.14406946 |
| 47 | * Lethargy (HP:0001254) | 3.12860331 |
| 48 | Delayed CNS myelination (HP:0002188) | 3.09756286 |
| 49 | Abnormality of the renal medulla (HP:0100957) | 3.05610686 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.03922763 |
| 51 | Abnormality of complement system (HP:0005339) | 3.00959382 |
| 52 | Myoglobinuria (HP:0002913) | 3.00818591 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98712666 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.98602563 |
| 55 | Abnormal biliary tract physiology (HP:0012439) | 2.93748719 |
| 56 | Bile duct proliferation (HP:0001408) | 2.93748719 |
| 57 | Hypercholesterolemia (HP:0003124) | 2.92965766 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.90935954 |
| 59 | Medial flaring of the eyebrow (HP:0010747) | 2.90809239 |
| 60 | Tubular atrophy (HP:0000092) | 2.89926993 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.88342302 |
| 62 | Hyperventilation (HP:0002883) | 2.75920496 |
| 63 | Abnormality of the renal cortex (HP:0011035) | 2.75541471 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.72354887 |
| 65 | Renal cortical cysts (HP:0000803) | 2.72149994 |
| 66 | Hepatic necrosis (HP:0002605) | 2.69952471 |
| 67 | Gait imbalance (HP:0002141) | 2.67420973 |
| 68 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.67324106 |
| 69 | * Vomiting (HP:0002013) | 2.63848393 |
| 70 | Congenital primary aphakia (HP:0007707) | 2.61002000 |
| 71 | Skin nodule (HP:0200036) | 2.60275634 |
| 72 | Occipital encephalocele (HP:0002085) | 2.58854632 |
| 73 | Cystic liver disease (HP:0006706) | 2.55056049 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.51778137 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.51778137 |
| 76 | Steatorrhea (HP:0002570) | 2.50587545 |
| 77 | Genital tract atresia (HP:0001827) | 2.49391042 |
| 78 | Myocardial infarction (HP:0001658) | 2.49142289 |
| 79 | Increased muscle lipid content (HP:0009058) | 2.49000900 |
| 80 | Nausea (HP:0002018) | 2.48395043 |
| 81 | Anophthalmia (HP:0000528) | 2.48388755 |
| 82 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.47876466 |
| 83 | Vaginal atresia (HP:0000148) | 2.46456919 |
| 84 | Increased purine levels (HP:0004368) | 2.46215128 |
| 85 | Hyperuricemia (HP:0002149) | 2.46215128 |
| 86 | Nephrogenic diabetes insipidus (HP:0009806) | 2.45030033 |
| 87 | Intestinal atresia (HP:0011100) | 2.43170233 |
| 88 | Abnormal ciliary motility (HP:0012262) | 2.42046971 |
| 89 | Glycosuria (HP:0003076) | 2.40660334 |
| 90 | Abnormality of urine glucose concentration (HP:0011016) | 2.40660334 |
| 91 | Methylmalonic aciduria (HP:0012120) | 2.40432249 |
| 92 | Genetic anticipation (HP:0003743) | 2.39828390 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.39692600 |
| 94 | Hepatocellular carcinoma (HP:0001402) | 2.37872344 |
| 95 | Vascular calcification (HP:0004934) | 2.36156868 |
| 96 | Colon cancer (HP:0003003) | 2.35711317 |
| 97 | Rhabdomyolysis (HP:0003201) | 2.34819824 |
| 98 | Postaxial foot polydactyly (HP:0001830) | 2.34758070 |
| 99 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.33579069 |
| 100 | Late onset (HP:0003584) | 2.31134444 |
| 101 | * Pancreatitis (HP:0001733) | 2.30705540 |
| 102 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.28910170 |
| 103 | Abolished electroretinogram (ERG) (HP:0000550) | 2.28459183 |
| 104 | Systemic lupus erythematosus (HP:0002725) | 2.26741310 |
| 105 | Anencephaly (HP:0002323) | 2.22027783 |
| 106 | Sensorimotor neuropathy (HP:0007141) | 2.21064502 |
| 107 | Pendular nystagmus (HP:0012043) | 2.20967240 |
| 108 | Bifid tongue (HP:0010297) | 2.20347259 |
| 109 | Abnormality of the labia minora (HP:0012880) | 2.19355424 |
| 110 | Sclerocornea (HP:0000647) | 2.15227859 |
| 111 | Postaxial hand polydactyly (HP:0001162) | 2.14612899 |
| 112 | Progressive cerebellar ataxia (HP:0002073) | 2.13840711 |
| 113 | Abnormal drinking behavior (HP:0030082) | 2.12209939 |
| 114 | Polydipsia (HP:0001959) | 2.12209939 |
| 115 | * Acute encephalopathy (HP:0006846) | 2.11645919 |
| 116 | Irritability (HP:0000737) | 2.11400354 |
| 117 | Rhinitis (HP:0012384) | 2.09939926 |
| 118 | Congenital hepatic fibrosis (HP:0002612) | 2.09772566 |
| 119 | Alkalosis (HP:0001948) | 2.09256866 |
| 120 | Cardiovascular calcification (HP:0011915) | 2.08621167 |
| 121 | Abnormal gallbladder morphology (HP:0012437) | 2.08126215 |
| 122 | Cholelithiasis (HP:0001081) | 2.07426783 |
| 123 | Malnutrition (HP:0004395) | 2.07373527 |
| 124 | Neonatal onset (HP:0003623) | 2.06652676 |
| 125 | Acute hepatic failure (HP:0006554) | 2.06611496 |
| 126 | Chronic bronchitis (HP:0004469) | 2.03970595 |
| 127 | Enlarged kidneys (HP:0000105) | 2.03642783 |
| 128 | Male pseudohermaphroditism (HP:0000037) | 2.03003961 |
| 129 | Poor coordination (HP:0002370) | 2.01600312 |
| 130 | Spontaneous abortion (HP:0005268) | 2.01584372 |
| 131 | Septo-optic dysplasia (HP:0100842) | 2.01026013 |
| 132 | Oligodactyly (hands) (HP:0001180) | 2.00546061 |
| 133 | Optic nerve hypoplasia (HP:0000609) | 2.00207093 |
| 134 | Preaxial hand polydactyly (HP:0001177) | 1.99142776 |
| 135 | Congenital stationary night blindness (HP:0007642) | 1.98955069 |
| 136 | Brushfield spots (HP:0001088) | 1.96789597 |
| 137 | Spastic diplegia (HP:0001264) | 1.96403149 |
| 138 | Hypertriglyceridemia (HP:0002155) | 1.95891146 |
| 139 | * Lactic acidosis (HP:0003128) | 1.95141647 |
| 140 | Methylmalonic acidemia (HP:0002912) | 1.95056751 |
| 141 | Symptomatic seizures (HP:0011145) | 1.93941785 |
| 142 | Supernumerary spleens (HP:0009799) | 1.93490727 |
| 143 | Elevated hepatic transaminases (HP:0002910) | 1.92916122 |
| 144 | Short tibia (HP:0005736) | 1.92383501 |
| 145 | Hyperglycemia (HP:0003074) | 1.92382848 |
| 146 | Abnormality of vitamin metabolism (HP:0100508) | 1.92169155 |
| 147 | Rib fusion (HP:0000902) | 1.90295665 |
| 148 | Gaze-evoked nystagmus (HP:0000640) | 1.90109747 |
| 149 | Labial hypoplasia (HP:0000066) | 1.90000536 |
| 150 | Opisthotonus (HP:0002179) | 1.89325040 |
| 151 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.88081014 |
| 152 | Ragged-red muscle fibers (HP:0003200) | 1.86859789 |
| 153 | Thyroid-stimulating hormone excess (HP:0002925) | 1.86293570 |
| 154 | Mitral stenosis (HP:0001718) | 1.86018674 |
| 155 | Abnormal cartilage morphology (HP:0002763) | 1.85969669 |
| 156 | Hepatocellular necrosis (HP:0001404) | 1.84774238 |
| 157 | Renal hypoplasia (HP:0000089) | 1.84496000 |
| 158 | Dandy-Walker malformation (HP:0001305) | 1.83928889 |
| 159 | Broad-based gait (HP:0002136) | 1.83434418 |
| 160 | Preaxial foot polydactyly (HP:0001841) | 1.83403744 |
| 161 | Polyuria (HP:0000103) | 1.81116647 |
| 162 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.80351992 |
| 163 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.80351992 |
| 164 | Increased intramyocellular lipid droplets (HP:0012240) | 1.79995646 |
| 165 | Esophageal varix (HP:0002040) | 1.79630567 |
| 166 | Tubulointerstitial nephritis (HP:0001970) | 1.79548287 |
| 167 | Narrow forehead (HP:0000341) | 1.78745952 |
| 168 | Lissencephaly (HP:0001339) | 1.75903158 |
| 169 | Decreased circulating renin level (HP:0003351) | 1.75230053 |
| 170 | Cutaneous finger syndactyly (HP:0010554) | 1.74977143 |
| 171 | Cerebellar dysplasia (HP:0007033) | 1.74923069 |
| 172 | Attenuation of retinal blood vessels (HP:0007843) | 1.72716193 |
| 173 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.72298766 |
| 174 | Abnormality of alanine metabolism (HP:0010916) | 1.72298766 |
| 175 | Hyperalaninemia (HP:0003348) | 1.72298766 |
| 176 | Abnormality of macular pigmentation (HP:0008002) | 1.70916521 |
| 177 | Absent/shortened dynein arms (HP:0200106) | 1.69860180 |
| 178 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69860180 |
| 179 | Retinitis pigmentosa (HP:0000510) | 1.64197086 |
| 180 | Tubulointerstitial abnormality (HP:0001969) | 1.63196393 |
| 181 | Broad foot (HP:0001769) | 1.63006537 |
| 182 | Hypoplastic female external genitalia (HP:0012815) | 1.62859139 |
| 183 | Type II lissencephaly (HP:0007260) | 1.61976340 |
| 184 | Abnormal urine output (HP:0012590) | 1.60419889 |
| 185 | Inability to walk (HP:0002540) | 1.59238193 |
| 186 | Gastrointestinal atresia (HP:0002589) | 1.57825795 |
| 187 | Hepatoblastoma (HP:0002884) | 1.56972937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.14697101 |
| 2 | SIK1 | 3.93953385 |
| 3 | ERN1 | 3.41396335 |
| 4 | INSRR | 3.10488467 |
| 5 | PDK4 | 2.96820416 |
| 6 | PDK3 | 2.96820416 |
| 7 | CASK | 2.88442396 |
| 8 | FGFR4 | 2.72447943 |
| 9 | TRIB3 | 2.62616672 |
| 10 | BMPR1B | 2.55301341 |
| 11 | ZAK | 2.54768629 |
| 12 | TAOK3 | 2.38234447 |
| 13 | ACVR1B | 2.35249537 |
| 14 | PKN2 | 2.33143341 |
| 15 | MAP3K4 | 2.23763803 |
| 16 | TNIK | 2.03694856 |
| 17 | LMTK2 | 2.03393106 |
| 18 | MARK1 | 1.99033261 |
| 19 | FLT3 | 1.97471757 |
| 20 | WNK4 | 1.93097049 |
| 21 | GRK1 | 1.90533944 |
| 22 | MKNK2 | 1.90198523 |
| 23 | STK16 | 1.89431738 |
| 24 | NUAK1 | 1.88391943 |
| 25 | MAP4K2 | 1.80661565 |
| 26 | PDK2 | 1.80537178 |
| 27 | NEK9 | 1.78273245 |
| 28 | CAMK1D | 1.70985477 |
| 29 | EPHA4 | 1.62115525 |
| 30 | PINK1 | 1.59076964 |
| 31 | BCR | 1.55272334 |
| 32 | MAPK11 | 1.53230389 |
| 33 | FRK | 1.50194326 |
| 34 | ADRBK2 | 1.48302828 |
| 35 | PRKAA2 | 1.47582518 |
| 36 | MAPK13 | 1.46092387 |
| 37 | MKNK1 | 1.41537704 |
| 38 | DYRK2 | 1.38709178 |
| 39 | MAP2K4 | 1.38502022 |
| 40 | PIK3CG | 1.34790639 |
| 41 | AKT3 | 1.32687586 |
| 42 | IRAK3 | 1.32656756 |
| 43 | ERBB4 | 1.31207956 |
| 44 | PNCK | 1.29902805 |
| 45 | MST1R | 1.25262521 |
| 46 | CAMK1G | 1.23637409 |
| 47 | TRIM28 | 1.23523736 |
| 48 | MAP2K7 | 1.19128224 |
| 49 | WNK3 | 1.18969688 |
| 50 | PTK6 | 1.17419233 |
| 51 | STK38L | 1.15790065 |
| 52 | LATS1 | 1.08463686 |
| 53 | PIK3CA | 1.06876150 |
| 54 | TIE1 | 1.04630312 |
| 55 | TTN | 1.04622802 |
| 56 | DAPK2 | 1.02986607 |
| 57 | MYLK | 1.01815364 |
| 58 | JAK1 | 1.01515320 |
| 59 | TYK2 | 1.01305885 |
| 60 | PRKAA1 | 1.01288227 |
| 61 | TLK1 | 1.00113573 |
| 62 | CSNK1G1 | 0.98677034 |
| 63 | JAK2 | 0.98085534 |
| 64 | PRKCG | 0.96610491 |
| 65 | STK3 | 0.95946237 |
| 66 | TGFBR1 | 0.94824010 |
| 67 | BRSK2 | 0.94284285 |
| 68 | CDK19 | 0.93353353 |
| 69 | MAP3K7 | 0.92055490 |
| 70 | ABL2 | 0.91959354 |
| 71 | OBSCN | 0.91136901 |
| 72 | CSNK1G2 | 0.86862671 |
| 73 | FER | 0.85487162 |
| 74 | OXSR1 | 0.83551153 |
| 75 | PHKG2 | 0.82515902 |
| 76 | PHKG1 | 0.82515902 |
| 77 | PRKCE | 0.82391953 |
| 78 | TBK1 | 0.81189217 |
| 79 | MAPK12 | 0.80714051 |
| 80 | SGK3 | 0.80190382 |
| 81 | SGK2 | 0.79528432 |
| 82 | MUSK | 0.77529346 |
| 83 | DYRK3 | 0.76704889 |
| 84 | PRKACG | 0.76112828 |
| 85 | WEE1 | 0.75593449 |
| 86 | MAP2K3 | 0.75384593 |
| 87 | PLK2 | 0.74542545 |
| 88 | NTRK2 | 0.74064856 |
| 89 | PDPK1 | 0.72526291 |
| 90 | NEK1 | 0.72508363 |
| 91 | KDR | 0.71327235 |
| 92 | CSNK1A1L | 0.70969009 |
| 93 | TGFBR2 | 0.70700830 |
| 94 | CSNK1G3 | 0.70595122 |
| 95 | MAPK15 | 0.69696136 |
| 96 | ERBB3 | 0.67612451 |
| 97 | CAMK1 | 0.67218881 |
| 98 | PLK4 | 0.67187961 |
| 99 | SRPK1 | 0.65952533 |
| 100 | EPHA3 | 0.61390182 |
| 101 | PKN1 | 0.60569260 |
| 102 | STK38 | 0.60150569 |
| 103 | NLK | 0.59792814 |
| 104 | PDK1 | 0.58174018 |
| 105 | MINK1 | 0.57982330 |
| 106 | TYRO3 | 0.57566294 |
| 107 | RIPK1 | 0.57122624 |
| 108 | SGK223 | 0.56850686 |
| 109 | SGK494 | 0.56850686 |
| 110 | MAPK4 | 0.56317153 |
| 111 | NEK2 | 0.55670093 |
| 112 | EPHB2 | 0.55112257 |
| 113 | CDK6 | 0.55030105 |
| 114 | CAMK2A | 0.54947336 |
| 115 | CAMK2G | 0.54444788 |
| 116 | PRKCZ | 0.51762413 |
| 117 | DYRK1A | 0.51224887 |
| 118 | FGFR3 | 0.51150759 |
| 119 | ADRBK1 | 0.50571009 |
| 120 | STK39 | 0.48265767 |
| 121 | PLK3 | 0.48049796 |
| 122 | MAP2K6 | 0.46717904 |
| 123 | PLK1 | 0.45868098 |
| 124 | CSNK1A1 | 0.45601089 |
| 125 | FGFR1 | 0.44803290 |
| 126 | IKBKE | 0.44493061 |
| 127 | CSNK1E | 0.42983470 |
| 128 | GSK3A | 0.42633414 |
| 129 | PDGFRA | 0.41642542 |
| 130 | MAP3K14 | 0.41600913 |
| 131 | RPS6KA5 | 0.41202587 |
| 132 | RPS6KA4 | 0.40802203 |
| 133 | EPHB1 | 0.40768129 |
| 134 | NTRK3 | 0.39840623 |
| 135 | NME1 | 0.39794384 |
| 136 | CSNK1D | 0.39209837 |
| 137 | VRK1 | 0.39081101 |
| 138 | PAK3 | 0.39077369 |
| 139 | PRKD1 | 0.39017064 |
| 140 | MAP2K1 | 0.38646356 |
| 141 | FGFR2 | 0.38328379 |
| 142 | IGF1R | 0.37755024 |
| 143 | GRK6 | 0.36721885 |
| 144 | CAMK4 | 0.35267047 |
| 145 | ERBB2 | 0.34867954 |
| 146 | MAPK7 | 0.33684445 |
| 147 | PRKACA | 0.31974446 |
| 148 | IRAK1 | 0.31785970 |
| 149 | PRKCH | 0.30357989 |
| 150 | CSF1R | 0.29627403 |
| 151 | MAP3K5 | 0.29390679 |
| 152 | PRKCQ | 0.27299947 |
| 153 | DYRK1B | 0.26692142 |
| 154 | TAOK2 | 0.26678617 |
| 155 | PRKCA | 0.23923989 |
| 156 | RPS6KB1 | 0.22653523 |
| 157 | EIF2AK1 | 0.22392214 |
| 158 | RET | 0.21519600 |
| 159 | MET | 0.21518414 |
| 160 | CDK4 | 0.21177955 |
| 161 | PRKACB | 0.19217839 |
| 162 | PRKG2 | 0.19185929 |
| 163 | MAP3K6 | 0.19178648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.74334065 |
| 2 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.15763479 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.09996968 |
| 4 | * Propanoate metabolism_Homo sapiens_hsa00640 | 3.03466834 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98949832 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.98083236 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93987903 |
| 8 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.83949482 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65484187 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57679191 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50656460 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.40596163 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.40004424 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.35899276 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24478105 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.21530386 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.19942615 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.16021071 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08921972 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.05613189 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.95816419 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89096440 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.76458683 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73561816 |
| 25 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.66569265 |
| 26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.55214911 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.54638134 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54045343 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52961575 |
| 30 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.52846507 |
| 31 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.52734692 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51376450 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47668063 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.45722892 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44647881 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44604522 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.39863870 |
| 38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36960731 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36942335 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.33283296 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31993082 |
| 42 | Phototransduction_Homo sapiens_hsa04744 | 1.29061549 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28461179 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.27965592 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.26299864 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22512566 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22036464 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19608279 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18977577 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11553089 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.09545523 |
| 52 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04582713 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.00039394 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99779997 |
| 55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99096699 |
| 56 | Protein export_Homo sapiens_hsa03060 | 0.97774403 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97700651 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94887722 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94257689 |
| 60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93980908 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93561244 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92712706 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.91690510 |
| 64 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86954709 |
| 65 | Basal transcription factors_Homo sapiens_hsa03022 | 0.86273729 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84425334 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83589670 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83433170 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.81915851 |
| 70 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81066205 |
| 71 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80129031 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79380526 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73049363 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.73004150 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.70121582 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69627525 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63878339 |
| 78 | GABAergic synapse_Homo sapiens_hsa04727 | 0.63703585 |
| 79 | RNA polymerase_Homo sapiens_hsa03020 | 0.61587943 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61399288 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.56196598 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.55474415 |
| 83 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.55308643 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52610495 |
| 85 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.50794739 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.50501387 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50445136 |
| 88 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49665336 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49265122 |
| 90 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.49067670 |
| 91 | Homologous recombination_Homo sapiens_hsa03440 | 0.47977552 |
| 92 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47226263 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47163715 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.46297959 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44727835 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44340087 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.43076185 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42949646 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.41757188 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.40454546 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.40229281 |
| 102 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40095896 |
| 103 | Axon guidance_Homo sapiens_hsa04360 | 0.38598004 |
| 104 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33449474 |
| 105 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.33069746 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26238695 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24401620 |
| 108 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24085739 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16055923 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.15276842 |
| 111 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12417182 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.09496889 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.09039197 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1314955 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1182821 |
| 116 | Lysosome_Homo sapiens_hsa04142 | -0.1107929 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1018610 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0930555 |
| 119 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0853476 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0751364 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0746614 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0706931 |
| 123 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0692955 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0579275 |
| 125 | Cardiac muscle contraction_Homo sapiens_hsa04260 | -0.0553567 |
| 126 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0520682 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0481086 |
| 128 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0323424 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.0063246 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0045971 |

